Kala Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
MRKMerck & Co., Inc. -4.12%74.860.7%$933.42m
PFEPfizer Inc. -4.12%32.700.9%$913.77m
JNJJohnson & Johnson -5.28%131.780.7%$912.02m
ABBVAbbVie, Inc. -2.75%83.082.3%$846.26m
BMYBristol-Myers Squibb Co. -3.54%57.471.0%$697.84m
LLYEli Lilly & Co. -5.44%122.161.1%$441.48m
NVSNovartis AG -3.19%83.280.2%$208.71m
GSKGlaxoSmithKline Plc -3.99%39.930.2%$159.35m
AZNAstraZeneca Plc -3.71%43.401.2%$147.46m
BHCBausch Health Cos., Inc. -3.29%21.780.0%$93.10m
RETAReata Pharmaceuticals, Inc. 1.44%191.403.4%$88.04m
SNYSanofi -4.82%45.840.2%$87.47m
NVONovo Nordisk A/S -3.28%57.540.1%$73.71m
GNPXGenprex, Inc. -13.25%4.060.0%$55.26m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 3.57%42.280.0%$53.52m

Company Profile

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.